Shang Hai Zheng Quan Bao·2025-12-01 15:31Group 1 - TaLong Pharmaceutical's controlling shareholder is planning a major matter, leading to a suspension of trading starting December 2, 2025, with an expected suspension period of no more than 2 trading days [1] - WeiLing Co., Ltd. is set to resume trading on December 2, 2025, after a control change agreement was signed, involving the transfer of 2,023,380 shares (7.7646% of total shares) to Tibet ShanNan Antimony Resources Co., Ltd. [2][3] - ST SuWu received a decision for stock delisting, with the last trading date expected to be December 29, 2025, entering a 15-day delisting adjustment period starting December 9, 2025 [4] Group 2 - Zhongjin Irradiation disclosed a plan to issue A-shares to specific investors, raising up to 800 million yuan for various projects, including sterilization technology centers [5] - Yingtai Energy plans to repurchase shares worth 300 million to 500 million yuan for cancellation, with a maximum repurchase price of 2.50 yuan per share [9] - The company Huayi Group has approved a plan to repurchase shares worth between 30 million and 50 million yuan for employee stock ownership plans [9] Group 3 - The company Chuanqi Technology is planning to issue A-shares to Hefei State-owned Capital Venture Investment Co., which may lead to a change in control [15] - BYD reported November 2025 new energy vehicle sales of 480,200 units, a decrease from 506,800 units in the same month last year, with a cumulative sales increase of 11.3% year-on-year [15] - The company Zhenhua Technology approved the acquisition of 51% stakes in Shenzhen Betel Electronics and Shanghai Tongtu Semiconductor, with total transaction amounts of 321 million yuan and 357 million yuan, respectively [16]